세계의 예방의료 기술 및 서비스 시장 : 성장, 향후 전망, 경쟁 분석(2025-2033년)

The preventive healthcare technologies and services market, primarily concerned with proactive health management, integrates technologies and services aimed at preventing the onset of diseases and health conditions rather than treating them post-diagnosis. This sector spans across a broad spectrum, from routine check-ups, vaccinations, health screenings to advanced preventive applications harnessing AI, telemedicine, and wearables. Preventive healthcare technologies and services market is estimated to grow at a CAGR of 11.6% from 2025 to 2033.

Driver: Rise in Chronic Disease Incidence

A monumental driver of the preventive healthcare technologies and services market has been the global surge in chronic diseases. With cardiovascular diseases, diabetes, and cancer becoming increasingly commonplace, the World Health Organization points out that chronic diseases account for approximately 71% of all global deaths. The spiraling healthcare costs associated with treating these ailments make a compelling case for investing in preventive measures. For instance, the American Heart Association highlighted that by 2035, over 130 million adults in the US might suffer from some form of cardiovascular disease, costing the system nearly $1.1 trillion. Emphasizing preventive healthcare could curtail these figures substantially, offering long-term economic and societal benefits.

Opportunity: Advancements in Wearable Health Technology

With technology permeating the health sector, wearable devices have opened up an ocean of opportunities. These gadgets, ranging from smartwatches to specialized wearables, can monitor vital statistics, detect irregular patterns, and even offer real-time feedback. A study published in the journal Nature unveiled a wearable device that could predict flu outbreaks in real-time, providing crucial data that could potentially curb widespread outbreaks. As technology continues to refine, the capability of these wearables in predicting and preventing potential health risks is expected to be a game-changer.

Restraint: Data Privacy Concerns

Despite the myriad advantages, data privacy emerges as a significant restraint. With increasing digital integration, the volume of health data being generated and shared is enormous. Reports of health data breaches have often hit the headlines, causing apprehensions among users. A survey conducted by the Pew Research Center indicated that 54% of Americans are somewhat concerned about data privacy, with 22% being very concerned. Such concerns, if not addressed, can hinder the adoption of preventive healthcare technologies, especially in the realm of digital solutions.

Challenge: Cultural and Socio-economic Barriers

Preventive healthcare, in theory, seems universally beneficial. However, cultural beliefs and socio-economic barriers often challenge its widespread adoption. In many societies, there's a deeply entrenched belief in tackling health problems as they arise rather than preemptively. Coupled with this, lower socio-economic strata often prioritize immediate concerns over long-term health investments. A UNICEF report highlighted how vaccination, a primary preventive measure, sees lesser adoption in regions with high poverty, due to a combination of unawareness, accessibility issues, and socio-cultural beliefs. Overcoming these deeply rooted challenges necessitates not just technological advancements but also comprehensive educational and outreach programs.

Market Segmentation by Type

Early Detection and screening Technologies contributed the highest revenue in 2024. These technologies, which encompass genetic testing, imaging, and routine medical screenings, have seen vast adoption across healthcare setups, providing proactive health solutions and timely interventions. On the other hand, the segment anticipated to showcase the highest Compound Annual Growth Rate (CAGR) from 2025 to 2033 is Advanced Technologies to Reduce Errors. With AI, machine learning, and advanced analytics, this segment is poised to revolutionize preventive healthcare by minimizing human error and maximizing efficiency, especially in diagnostic procedures.

Regional Analysis

Geographically, North America secured the throne with the highest revenue percent in 2024, primarily due to its advanced healthcare infrastructure, higher healthcare expenditure, and the rapid adoption of technological advancements. However, the Asia-Pacific region is expected to display the highest CAGR from 2025 to 2033. Factors propelling this growth include rising awareness about preventive measures, increasing disposable incomes, technological adoption, and burgeoning healthcare sectors in countries like India and China.

Competitive Landscape

2025 was a year of consolidation and innovation in the preventive healthcare technologies and services market. Top players like Myriad Genetics, Inc., Quest Diagnostics Incorporated, Medtronic, Abbott, Merck & Co., Inc., GSK plc, Omnicell, MCKESSON CORPORATION remained dominant, leveraging their robust R&D capacities and expansive distribution networks. Their key strategies included partnerships with tech companies for AI integrations, acquisitions of startups with innovative solutions, and extensive consumer education campaigns. There's an observable trend of these giants investing heavily in digital platforms, wearables, and telehealth solutions, anticipating the future shift in healthcare paradigms. From 2025 to 2033, it's expected that these players, along with emerging innovators, will intensely focus on personalized healthcare solutions, driven by AI and machine learning, aiming to offer more tailored and accurate preventive measures to individuals.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Preventive Healthcare Technologies And Services market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Preventive Healthcare Technologies And Services market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

• Market Segmentation
• Type
• Early Detection & Screening Technologies
• Automated Screening Market
• Personalized Medicine Market
• Other Advanced Screening Technologies
  • Chronic Disease Management Technologies
• Blood Pressure Monitors
• Asthma Monitors
• Cardiovascular Monitors
• Glucose Monitors
  • Vaccines
• Infectious Diseases
• Cancer
• Autism
• Allergy
• Others
  • Advanced Technologies to Reduce Errors
• Electronic Prescribing
• Clinical Decision Support System
• Smart Infusion Pumps
• Computerized Provider Order Entry System
• Smart Packaging
• Automated Prescription Formulation & Dispensing
• End-Use
• Hospitals
• Clinics
• Other end-Users
• Region Segment (2023-2033; US$ Million)
• North America
• U.S.
• Canada
• Rest of North America
• UK and European Union
• UK
• Germany
• Spain
• Italy
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• GCC
• Africa
• Rest of Middle East and Africa

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Preventive Healthcare Technologies And Services market?
• What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2033.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Preventive Healthcare Technologies And Services market?
• Which is the largest regional market for Preventive Healthcare Technologies And Services market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Preventive Healthcare Technologies And Services market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Preventive Healthcare Technologies And Services market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Preventive Healthcare Technologies And Services Market
• 2.2. Global Preventive Healthcare Technologies And Services Market, By Type, 2024 (US$ Million)
• 2.3. Global Preventive Healthcare Technologies And Services Market, By End-Use, 2024 (US$ Million)
• 2.4. Global Preventive Healthcare Technologies And Services Market, By Geography, 2024 (US$ Million)
• 2.5. Attractive Investment Proposition by Geography, 2024

3. Preventive Healthcare Technologies And Services Market: Competitive Analysis

• 3.1. Market Positioning of Key Preventive Healthcare Technologies And Services Market Vendors
• 3.2. Strategies Adopted by Preventive Healthcare Technologies And Services Market Vendors
• 3.3. Key Industry Strategies

4. Preventive Healthcare Technologies And Services Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global Preventive Healthcare Technologies And Services Market Value, 2023 - 2033, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis
• 4.6. Porter's Five Force Model
  • 4.6.1. Supplier Power
  • 4.6.2. Buyer Power
  • 4.6.3. Threat Of Substitutes
  • 4.6.4. Threat Of New Entrants
  • 4.6.5. Competitive Rivalry
• 4.7. PESTEL Analysis
  • 4.7.1. Political Landscape
  • 4.7.2. Economic Landscape
  • 4.7.3. Technology Landscape
  • 4.7.4. Legal Landscape
  • 4.7.5. Social Landscape

5. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2024 Versus 2033
• 5.3. Market Segmentation
  • 5.3.1. Early Detection & Screening Technologies
    • 5.3.1.1. Automated Screening Market
    • 5.3.1.2. Personalized Medicine Market
    • 5.3.1.3. Other Advanced Screening Technologies
  • 5.3.2. Chronic Disease Management Technologies
    • 5.3.2.1. Blood Pressure Monitors
    • 5.3.2.2. Asthma Monitors
    • 5.3.2.3. Cardiovascular Monitors
    • 5.3.2.4. Glucose Monitors
  • 5.3.3. Vaccines
    • 5.3.3.1. Infectious Diseases
    • 5.3.3.2. Cancer
    • 5.3.3.3. Autism
    • 5.3.3.4. Allergy
    • 5.3.3.5. Others
  • 5.3.4. Advanced Technologies to Reduce Errors
    • 5.3.4.1. Electronic Prescribing
    • 5.3.4.2. Clinical Decision Support System
    • 5.3.4.3. Smart Infusion Pumps
    • 5.3.4.4. Computerized Provider Order Entry System
    • 5.3.4.5. Smart Packaging
    • 5.3.4.6. Automated Prescription Formulation & Dispensing

6. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)

• 6.1. Market Overview
• 6.2. Growth & Revenue Analysis: 2024 Versus 2033
• 6.3. Market Segmentation
  • 6.3.1. Hospitals
  • 6.3.2. Clinics
  • 6.3.3. Other end-Users

7. North America Preventive Healthcare Technologies And Services Market, 2023-2033, USD (Million)

• 7.1. Market Overview
• 7.2. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
• 7.3. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
• 7.4.Preventive Healthcare Technologies And Services Market: By Region, 2023-2033, USD (Million)
  • 7.4.1.North America
    • 7.4.1.1. U.S.
      • 7.4.1.1.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 7.4.1.1.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 7.4.1.2. Canada
      • 7.4.1.2.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 7.4.1.2.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 7.4.1.3. Rest of North America
      • 7.4.1.3.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 7.4.1.3.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)

8. UK and European Union Preventive Healthcare Technologies And Services Market, 2023-2033, USD (Million)

• 8.1. Market Overview
• 8.2. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
• 8.3. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
• 8.4.Preventive Healthcare Technologies And Services Market: By Region, 2023-2033, USD (Million)
  • 8.4.1.UK and European Union
    • 8.4.1.1. UK
      • 8.4.1.1.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 8.4.1.1.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 8.4.1.2. Germany
      • 8.4.1.2.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 8.4.1.2.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 8.4.1.3. Spain
      • 8.4.1.3.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 8.4.1.3.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 8.4.1.4. Italy
      • 8.4.1.4.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 8.4.1.4.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 8.4.1.5. France
      • 8.4.1.5.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 8.4.1.5.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 8.4.1.6. Rest of Europe
      • 8.4.1.6.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 8.4.1.6.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)

9. Asia Pacific Preventive Healthcare Technologies And Services Market, 2023-2033, USD (Million)

• 9.1. Market Overview
• 9.2. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
• 9.3. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
• 9.4.Preventive Healthcare Technologies And Services Market: By Region, 2023-2033, USD (Million)
  • 9.4.1.Asia Pacific
    • 9.4.1.1. China
      • 9.4.1.1.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 9.4.1.1.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 9.4.1.2. Japan
      • 9.4.1.2.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 9.4.1.2.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 9.4.1.3. India
      • 9.4.1.3.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 9.4.1.3.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 9.4.1.4. Australia
      • 9.4.1.4.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 9.4.1.4.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 9.4.1.5. South Korea
      • 9.4.1.5.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 9.4.1.5.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 9.4.1.6. Rest of Asia Pacific
      • 9.4.1.6.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 9.4.1.6.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)

10. Latin America Preventive Healthcare Technologies And Services Market, 2023-2033, USD (Million)

• 10.1. Market Overview
• 10.2. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
• 10.3. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
• 10.4.Preventive Healthcare Technologies And Services Market: By Region, 2023-2033, USD (Million)
  • 10.4.1.Latin America
    • 10.4.1.1. Brazil
      • 10.4.1.1.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 10.4.1.1.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 10.4.1.2. Mexico
      • 10.4.1.2.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 10.4.1.2.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 10.4.1.3. Rest of Latin America
      • 10.4.1.3.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 10.4.1.3.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)

11. Middle East and Africa Preventive Healthcare Technologies And Services Market, 2023-2033, USD (Million)

• 11.1. Market Overview
• 11.2. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
• 11.3. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
• 11.4.Preventive Healthcare Technologies And Services Market: By Region, 2023-2033, USD (Million)
  • 11.4.1.Middle East and Africa
    • 11.4.1.1. GCC
      • 11.4.1.1.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 11.4.1.1.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 11.4.1.2. Africa
      • 11.4.1.2.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 11.4.1.2.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)
    • 11.4.1.3. Rest of Middle East and Africa
      • 11.4.1.3.1. Preventive Healthcare Technologies And Services Market: By Type, 2023-2033, USD (Million)
      • 11.4.1.3.2. Preventive Healthcare Technologies And Services Market: By End-Use, 2023-2033, USD (Million)

12. Company Profile

• 12.1. Myriad Genetics, Inc.
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Portfolio
  • 12.1.4. Strategic Initiatives
• 12.2. Quest Diagnostics Incorporated
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Portfolio
  • 12.2.4. Strategic Initiatives
• 12.3. Medtronic
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Portfolio
  • 12.3.4. Strategic Initiatives
• 12.4. Abbott
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Portfolio
  • 12.4.4. Strategic Initiatives
• 12.5. Merck & Co., Inc.
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Portfolio
  • 12.5.4. Strategic Initiatives
• 12.6. GSK plc
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Portfolio
  • 12.6.4. Strategic Initiatives
• 12.7. Omnicell
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Portfolio
  • 12.7.4. Strategic Initiatives
• 12.8. MCKESSON CORPORATION
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Portfolio
  • 12.8.4. Strategic Initiatives
• 12.9. Others
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Portfolio
  • 12.9.4. Strategic Initiatives